CP - Straight from the last Investor Update - pg 3
"First is the continued development of CVacTM’s safety profile. With each new patient, we have additional confidence that CVacTM is a well tolerated and non-toxic treatment. The last patient will receive the last dose of CVacTM in October. An update on safety data can then be expected before the end of 2012"
Lots more exciting stuff in the pipeline also -
http://www.primabiomed.com.au/investor/investor_update_pdf/Prima_Newsletter_JUNE_2012_RZ02_screen.pdf
Cheers
- Forums
- ASX - By Stock
- no movement
CP - Straight from the last Investor Update - pg 3 "First is the...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
33.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $486.6M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.8¢ | $80.82K | 242.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29609 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 334991 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 26961 | 0.335 |
15 | 148187 | 0.330 |
7 | 65553 | 0.325 |
8 | 93318 | 0.320 |
8 | 93320 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 341057 | 14 |
0.345 | 178741 | 11 |
0.350 | 106399 | 11 |
0.355 | 188227 | 11 |
0.360 | 310353 | 9 |
Last trade - 10.27am 15/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online